Don’t miss outtag icon
Are you tracking AI visibility, or guessing? Get clarity with Similarweb’s AEO ToolkitTry it nowbanner icon

Crohn's Disease by AZoMedical análises de aplicativos para 15 de janeiro

Crohn's Disease by AZoMedical

Crohn's Disease by AZoMedical

  • AZoNetwork
  • Apple App Store
  • Gratuitos
  • Médico
Crohn’s Disease by AZoMedical.com is a free app that provides regularly updated information and news on Crohn’s disease. Crohn’s disease is a chronic inflammatory disease of the bowel affecting at least 115,000 people in the UK. The condition usually develops in teenagers and young adults, but can be diagnosed at any age and is equally common in men and women. Crohn’s Disease by AZoMedical.com is produced by AZoNetwork, a leading free-access online information provider for health care professionals, scientists, engineers and technologists. An internet connection is not required to use this app; however, any subsequent updates will require an internet connection.
Crohn's Disease by AZoMedical

Ranking da Loja

A Store Rank é baseado em vários parâmetros definidos pelo Google e Apple.

Todas as categorias em
Estados Unidos--
Médico em
Estados Unidos--
Crie uma conta para ver os downloads médios mensaisFale conosco

Crohn's Disease by AZoMedical Estatísticas de classificação ao longo do tempo

"Ranking de Uso do Similarweb e Ranking de Apple App Store para Crohn's Disease by AZoMedical

Classificação

Nenhum dado disponível

Crohn's Disease by AZoMedical Classificação por país

Países nos quais Crohn's Disease by AZoMedical tem a classificação mais alta em suas principais categorias

Nenhum dado para exibir

Principais concorrentes e aplicativos alternativos

Aplicativos com alta probabilidade de serem usados pelos mesmos usuários, da mesma loja.

Crohn’s Tracker: Food & IBD

Crohn’s Tracker: Food & IBD

Elco Dev, LLC

Crohn's Disease +

Crohn's Disease +

Personal Remedies, LLC

The IBD Digest

The IBD Digest

David Vi Tran

IBD Classes

IBD Classes

SOLUS UK Ltd

Crohn's Disease by AZoMedical VS.

janeiro 15, 2026